000 04071nam a22005055i 4500
001 vtls000561197
003 RU-ToGU
005 20210922090534.0
007 cr nn 008mamaa
008 170213s2015 gw | s |||| 0|eng d
020 _a9783642365720
_9978-3-642-36572-0
024 7 _a10.1007/978-3-642-36572-0
_2doi
035 _ato000561197
040 _aSpringer
_cSpringer
_dRU-ToGU
050 4 _aRC254-282
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a616.994
_223
245 1 0 _aLocoregional Tumor Therapy
_helectronic resource
_cedited by Eric Van Cutsem, Thomas J. Vogl, Franco Orsi, Alberto Sobrero.
260 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg :
_bImprint: Springer,
_c2015.
300 _aVI, 161 p. 6 illus., 3 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
505 0 _aBasics of Regional Tumor therapies: Locoregional Tumor Therapies, Evidence and Future -- Pharmacokinetic of Locoregional Tumor Therapies -- Embolization Materials, Catheter, IA-port systems Indications for locoregional tumor therapies – Liver: HCC -- Liver Metastases of CRC- Liver Metastases of Neuroendocrine Tumors and CCC -- Liver metastases of other indications: Pancreas Carcinoma -- Melanoma -- Breast Carcinoma. Indications for locoregional tumortherapies – Lung: Basics -- Primary Lung Tumors -- Lung metastases Thermoablation: Liver -- Lung. Head and Neck.
520 _aRecent years have witnessed a renaissance in the use of locoregional tumor therapy as part of a multimodal therapeutic approach to a variety of solid tumors, and attempts are underway to define its value in the overall therapeutic strategy for individual tumor entities. This flourishing of interest in locoregional tumor therapy derives from a series of important new developments concerning methodology, drug treatments, and instrumentation. The resulting approaches include not only optimized locoregional chemotherapy and chemoembolization for hepatocellular carcinoma and other tumors, but also other “targeted” therapies such as stereotactic radiosurgery, radiofrequency ablation, intra-arterial administration of radiopharmaceuticals, and complex new methods of chemoembolization of liver metastases involving the use of multiagent chemotherapy in combination with targeted drugs, drug-eluting beads/microspheres, or nanoparticles. In addition, intraperitoneal and intrapleural therapies, e.g., cytoreduction plus hyperthermic intraperitoneal chemotherapy, are now a standard element of the strategy for a range of tumors. It is vital that practitioners have the necessary expertise in the use of these locoregional treatment methods and understand how to combine them optimally with modern systemic therapies. With that goal in mind, this book presents, in condensed form, the clinical results achieved using various locoregional tumor therapies. In so doing, it will allow the reader to rapidly retrieve the information on indications and effectiveness that is required for optimal integration of these highly effective therapies into modern, yet more complex treatment strategies.
650 0 _amedicine.
_9566220
650 0 _aInterventional radiology.
_9566394
650 0 _aOncology.
_9303086
650 0 _aSurgical Oncology.
_9303089
650 1 4 _aMedicine & Public Health.
_9566221
650 2 4 _aOncology.
_9303086
650 2 4 _aInterventional Radiology.
_9566395
650 2 4 _aSurgical Oncology.
_9303089
700 1 _aVan Cutsem, Eric.
_eeditor.
_9469099
700 1 _aVogl, Thomas J.
_eeditor.
_9319836
700 1 _aOrsi, Franco.
_eeditor.
_9469100
700 1 _aSobrero, Alberto.
_eeditor.
_9469101
710 2 _aSpringerLink (Online service)
_9143950
773 0 _tSpringer eBooks
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-642-36572-0
912 _aZDB-2-SME
999 _c416249